Why Is HIMS & HERS HEALTH I A (HIMS) Stock Down Today?

HIMS stock is down 7.84% at $31.13 as of the latest trade, marking a sharp reversal from its recent upward trend. The stock opened with a 2.9% gap down and has since drifted lower, hitting an intraday low of $30.30. The move follows a broader selloff in the health care sector and a mixed earnings backdrop for the company.

What Happened

The stock’s sharp decline came after it opened at $32.79, below its prior close of $33.78. Volume has so far reached 3.7 million shares, more than double the 3-month daily average. The selloff appears to have been triggered by a combination of profit-taking and broader market concerns. HIMS has seen recent positive momentum, rising 15.7% over the past eight sessions from $29.62 to $34.28, but the recent pullback has pushed it closer to its 52-week low of $13.74. Meanwhile, Barclays cut its price target for HIMS to $35, maintaining an Overweight rating. The company also faces ongoing scrutiny over privacy allegations, which it has denied while pledging to expand patient access.

What The Data Shows

The stock has printed one fresh 52-week low on 2026-08-24 and has seen unusual put activity, with a notable print of $323K. Over the last 90 days, insiders have sold more than they have bought, with 11 sales totaling $7.2 million compared to 1 buy totaling $1.2 million. The most recent insider transaction was on 2026-08-20. HIMS remains unprofitable, with a trailing twelve-month net margin of -5.5% and an EPS of -0.62, despite revenue growth of 28.0% TTM.

What To Watch

The company is not scheduled to report earnings in the near term. Investors should monitor coverage breadth and any further insider activity for additional clues about the stock’s direction.